Avanos Medical, Inc. (AVNS)
Avanos Medical Market Cap : 1.166B for June 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 09, 2026 | 1.168B |
| June 08, 2026 | 1.167B |
| June 05, 2026 | 1.169B |
| June 04, 2026 | 1.167B |
| June 03, 2026 | 1.166B |
| June 02, 2026 | 1.166B |
| June 01, 2026 | 1.169B |
| May 29, 2026 | 1.157B |
| May 28, 2026 | 1.156B |
| May 27, 2026 | 1.161B |
| May 26, 2026 | 1.159B |
| May 22, 2026 | 1.152B |
| May 21, 2026 | 1.157B |
| May 20, 2026 | 1.158B |
| May 19, 2026 | 1.159B |
| May 18, 2026 | 1.158B |
| May 15, 2026 | 1.157B |
| May 14, 2026 | 1.157B |
| May 13, 2026 | 1.158B |
| May 12, 2026 | 1.158B |
| May 11, 2026 | 1.162B |
| May 08, 2026 | 1.161B |
| May 07, 2026 | 1.160B |
| May 06, 2026 | 1.158B |
| May 05, 2026 | 1.157B |
| Date | Value |
|---|---|
| May 04, 2026 | 1.155B |
| May 01, 2026 | 1.155B |
| April 30, 2026 | 1.153B |
| April 29, 2026 | 1.146B |
| April 28, 2026 | 1.145B |
| April 27, 2026 | 1.145B |
| April 24, 2026 | 1.147B |
| April 23, 2026 | 1.149B |
| April 22, 2026 | 1.146B |
| April 21, 2026 | 1.146B |
| April 20, 2026 | 1.146B |
| April 17, 2026 | 1.145B |
| April 16, 2026 | 1.147B |
| April 15, 2026 | 1.150B |
| April 14, 2026 | 1.145B |
| April 13, 2026 | 675.76M |
| April 10, 2026 | 659.48M |
| April 09, 2026 | 655.29M |
| April 08, 2026 | 647.39M |
| April 07, 2026 | 636.69M |
| April 06, 2026 | 643.20M |
| April 02, 2026 | 648.78M |
| April 01, 2026 | 655.29M |
| March 31, 2026 | 651.57M |
| March 30, 2026 | 638.55M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Boston Scientific Corp. | 71.83B |
| Embecta Corp. | 190.44M |
| Abbott Laboratories | 155.23B |
| AngioDynamics, Inc. | 511.44M |
| Alphatec Holdings, Inc. | 1.236B |
Market Cap Related Metrics
| PS Ratio | 1.628 |
| Price to Book Value | 1.491 |
| Price to Free Cash Flow | 155.44 |
| Price | 24.99 |
| Earnings Yield | -6.44% |
| Operating PE Ratio | 33.50 |